Tardive Dyskinesia Medical
Saturday, 20 December 2008
Psychiatr Danub. 2008 Dec;20(4):461-5
 
Ten year outcome of tardive dyskinesia during continuous treatment with first generation antipsychotics.
Rittmannsberger H.
Department of Psychiatry 1, Landesnervenklink Wagner-Jauregg, Linz, Austria.

OBJECTIVE: The aim of this study is to determine the course of tardive dyskinesia (TD) during continuous medication with first generation antipsychotics.

SUBJECTS AND METHODS: Patients of a psychiatric nursing home were assessed for TD by means of the AIMS on two occasions ten years apart.

RESULTS: Out of 10 patients who met criteria for TD at baseline the global judgement of severity of the AIMS improved in 5, worsened in 4 and remained unchanged in one patient. The mean sum score of the AIMS slightly increased from 5.5 to 6.3. No patient developed movements that incapacitated him in his daily activities.

CONCLUSION: In concordance with the available literature these findings support the view that under continuous treatment with antipsychotics there is an equal chance for improvement as for deterioration. Progressive worsening to severe forms of TD was not observed.

PMID: 19011586
POSTED BY: dw AT 04:33 pm   |  Permalink   |  E-mail this

Tardive Dyskinesia Web for TD treatment, Tardive Dyskinesia Symptoms, causes and the latest news on Metoclopramide Reglan Lawsuit  Litigation and Settlements and any news of a FDA Reglan Recall Talk to Reglan side effects metoclopramide lawyer about filing a metoclopramide lawsuit, metoclopramide Reglan lawsuit , side effects from metoclopramide reglan drug, metoclopramide reglan class action lawsuit and possible metoclopramide recall news

WILLIS LAW FIRM 1221 McKinney # 3333  Houston, Texas 77010

 Call Toll Free at 1-888-5-TARDIVE

THIS WEBSITE IS ATTORNEY ADVERTISING

_____________________________________________________________________________________________